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Transmission of Plasmodium parasites to the mosquito requires the formation and development of gametocytes.
Studies in infected humans have shown that only the most mature forms of Plasmodium falciparum gametocytes are
present in circulation, whereas immature forms accumulate in the hematopoietic environment of the bone marrow.
We used the rodent model Plasmodium berghei to study gametocyte behavior through time under physiological con-
ditions. Intravital microscopy demonstrated preferential homing of early gametocyte forms across the intact vascular
barrier of the bone marrow and the spleen early during infection and subsequent development in the extravascular
environment. During the acute phase of infection, we observed vascular leakage resulting in further parasite accumu-
lation in this environment. Mature gametocytes showed high deformability and were found entering and exiting the
intact vascular barrier. We suggest that extravascular gametocyte localization and mobility are essential for gameto-
cytogenesis and transmission of Plasmodium to the mosquito.http
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Transmission to mosquitoes is an essential part of the Plasmodium
parasite’s life cycle and a target of current intervention strategies.During
transmission, gametocytes are ingested by mosquitoes where they
undergo exflagellation and fertilization, leading tomassive parasite rep-
lication. In the human-infective Plasmodium falciparum parasite, five
developmental stages of gametocytes have been defined (referred to
as stages I to V), of which only stage V forms are present in peripheral
circulation (1). Postmortem analyses, as well as aspirates and biopsies of
human tissues, have consistently revealed the presence of immature ga-
metocytes (stages I to IV) in the bone marrow (BM) and the spleen of
infected individuals (2–7). In a systematic analysis of human autopsies,
we recently demonstrated that immature gametocytes are specifically
enriched in the BM parenchyma, an extravascular niche that is sep-
arated from the blood by the vascular endothelium. In this niche, game-
tocytes are protected from immune clearance and are able to attach to
and developwithin erythroid precursor cells (6). These findings support
a testable model in which parasites home to the BM, move across the
endothelium, and uponmaturation in the parenchyma intravasate intocirculation as mature gametocytes. These processes require as yet un-
characterized modes of mobile behavior. Because such behavior can-
not be tested in humans because of ethical reasons, we turned to the
rodent malaria model Plasmodium berghei. Quantitative imaging
experiments in this animal model and comparative histology in human
autopsies provide first evidence for a conserved BM localization
phenotype of Plasmodium gametocytes, involving selective tissue
homing, transendothelial migration, and mobility of infected red blood
cells (iRBCs).RESULTS
P. berghei parasites accumulate in the extravascular niche
of the mouse reticuloendothelial system
The presence of P. berghei parasites across several mouse tissues was
assessed by bioluminescence and fluorescence imagingmethods. To spe-
cifically investigate gametocyte tissue distribution, we induced gameto-
cytogenesis and eliminated asexual parasite populations using a combined
treatment of phenylhydrazine and sulfadiazine (PH-S) (as described in
Materials and Methods) (8). In addition, we used transgenic parasite
lines with fluorescent reporters to differentiate asexual from gametocyte
stages (note that all parasites analyzed except for invasivemerozoites are
contained within an RBC). We observed gametocyte enrichment in the
reticuloendothelial system (BM, spleen, and liver) of Balb/c andC57BL/
6 mice at multiple times after infection. Comparative intravital, ex vivo,
and bioluminescence imaging revealed an enrichment of both schizonts
and gametocytes in BM, liver, and spleen (Fig. 1, A andC, and fig. S1A),
although schizonts preferentially accumulated in the lungs and adipose
tissue, as described previously (9, 10). Analysis of transgenic mice
expressing green fluorescent protein (GFP) under the control of the
ubiquitin promoter in all tissues (UBC-GFP) (11), or expressing GFP
in the vascular endothelium across all tissues (Flk1-GFP) (12), further
demonstrated significant extravascular parasite enrichment in BM,
spleen, and liver (Fig. 1, C and D). This in vivo evidence for parasite
endothelial localizationwas confirmedby ex vivo stainingwith antibodies1 of 15
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 Fig. 1. Parasite distribution in rodent tissues. (A to C) Bioluminescence and intravital imaging and ex vivo quantification in ice infectedwith transgenic P. berghei coexpressing
mCherry and luciferase reporters (mCherryHsp70-FLucef1a) (36). (A) Representative images show bioluminescence signal in the BM (femur and pelvic bones marked by arrow), in
mice at (i) 65 hours following sporozoite infection, namely, after completion of the pre-erythrocytic stages, immediately following egress of merozoites from the liver to begin the
first blood stage cycle; (ii) at 22 hours following infection with nonsequestering (N.S.) schizonts (that is, thereby, the only population detected at this time point are schizonts of the
immediate next cycle) (9); and at day 7 (d7) postinfection (pi) with mixed blood stage parasites without (iii) or with (iv) pretreatment with PH-S (PH-S will select for gametocytes while
killing the asexual populations of parasites). Note that the signal from theBM is potentially obscuredby that of the adipose tissue in (iii), but not in (ii) becauseof the lack of sequestration
phenotype. hpi, hourspost-invasion. (B) Bioluminescence-basedquantificationof individual extractedorgans from15mice (5 in triplicate experiments) infectedwitheither synchronous
schizonts (black bars) or after PH-S treatment (red bars). Bars indicate luminescence (g/s), normalized to and expressed as a ratio of schizont signal in the brain. Arrows show that the
largest relative gametocyte signal occurs in spleen and BM. AT (ab), abdominal adipose tissue. (C) Representative intravital and/or ex vivo images of mCherryHsp70-FLucef1a P. berghei
gametocytes (red) in various tissues of transgenicmice treated with PH-S (green) expressing either UBC-GFP (top panels) or Flk1-GFP (bottompanels). Lung, abdominal adipose tissue,
heart, and brain show gametocytes in vasculature, whereas liver, spleen, and BM also show extravascular gametocytes. Scale bars, 20 mm. (D) CD31- and Flk1-based immuno-
fluorescence quantification of vascular versus extravascular mCherryHsp70-FLucef1a P. berghei distribution in mice after asexual blood stage infection. Highest extravascular parasite
levels are observed in the spleen, BM, and liver (white stacked bars). Error bars represent SDs of quantifications in 25 fields of view across 18 separate mice. (E) Schematic showing
specific fluorescence of gametocyte producer (Con and EG) or nonproducer (GNP) P. berghei lines, under constitutive (Con-CFP and GNP-CFP) or early gametocyte–specific promoters
(EG-CFP). (F)Distributionofgametocyteproducerandnonproducer lineswithin theparenchyma (P), sinusoids (S), and intravascular (IV) spacesof BM, spleen, and liver ofmiceatday4pi.
Con-CFP parasites are equally distributed across BM and spleen compartments. In contrast, EG-CFP parasites are enriched in parenchyma and sinusoids, whereas GNP parasites are
enriched in the vasculature. Error bars represent SDs of quantification in 25 fields of view across 30 separate mice. (G) Extravascular parasites in the BM localize to sinusoids and the
parenchyma, as defined by ICAM-1 labeling (yellow). The inset in the ICAM-1 image shows gametocytes in close distance to the sinusoidal lining (left panel). Scale bars, 20 mm. For all
experiments, three to five mice were used per triplicate experiment, and at least 25 fields of view were quantified per mouse.De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018 2 of 15
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 specific for CD31 and ICAM-1 (intercellular adhesion molecule–1),
markers for the vascular endothelium (fig. S1, B to D). These results
confirm early observations by Weiss (13) and Singer (14) who first de-
scribed parasites in this location in the rodent model. Next, we used a
series of transgenic parasite lines with stage-specific fluorescent report-
ers (15) including constitutive cyan fluorescent protein (Con-CFP),
early-gametocyte CFP (EG-CFP), and gametocyte nonproducer CFP
(GNP-CFP) lines to directly differentiate asexual from gametocyte
stages and define their localization across tissues by quantification in
ex vivo tissue sections (Fig. 1E; see also fig. S1E for methods). Gameto-
cytes were highly enriched in the parenchyma and sinusoids of BM and
spleen and in liver sinusoids, whereasmost asexual parasites were found
in the peripheral vasculature of most organs (Fig. 1, F and G). Overall,
the localization of parasites across mouse tissues and the preferential
localization of gametocytes to the extravascular niche of the reticulo-
endothelial system (that is, sinusoids and parenchyma) recapitulated
our previous findings in human autopsies (6) and recent data from
the humanized mouse model (16). Notably, extravascular parasites in
mice are largely protected from phagocytosis by macrophages (fig. S2,
A and B), consistent with previous observations in human autopsies (6).
Selective homing of a subset of parasites to the BM niche
Twomutually compatiblemodels have been proposed to explain game-
tocyte enrichment in the extravascular space of the BM in humans
(17): (i) selective homing of a subset of parasites [either sexualmerozoites
(that is, merozoites contained in a sexually committed schizont) or young
gametocytes] to BM from an outside site of formation or (ii) an endog-
enous asexual cycle promoting replication and gametocyte formation
in the BM. To test these models, P. berghei parasites were synchronized
ex vivo and injected either directly into the recipient mice or to inter-
mediate donor mice for further development. Synchronized infections
of individual parasite stages demonstrated that parasites injected di-
rectly after mechanical rupture of schizonts to release merozoites, as
well as purified ring stages and purified gametocytes, showed highest
enrichment in BM, spleen, and lungs within 2 hours after infection
(Fig. 2A). In each case, stages were synchronized before injection, and
each of the stages was specific (that is, no mixed stages were injected).
To determine whether merozoites invade RBCs in the BM or en route,
we quantified the fraction of injected merozoites that was present in
BM-resident RBC precursor cells (determined by CD44+ expression)
(Fig. 2, B and C) (18). At 24 hours after infection, most of the gameto-
cytes were present in RBC precursor cells in the BM parenchyma and
sinusoids, whereas asexual parasites were equally distributed in BM ex-
travascular and intravascular compartments and in the peripheral cir-
culation at any time after infection (Fig. 2C). This localization pattern
was consistent between 2 hours and 4 days after infection (fig. S2C).
Together, these observations support bothmodels: They strongly suggest
that asexual and gametocyte stages can form in the BM upon merozoite
invasion of BM-resident RBCs; the presence of parasites in CD44−
RBCs and efficient BM homing of ring stages (Fig. 2A) suggests that
circulating iRBCs may also enter the extravascular niche, similar to
observationsmadewith uninfected RBCs (uRBCs) (Fig. 2D). The pres-
ence of a subset of parasites in CD44− RBCs may also be the result of
accelerated RBC maturation upon parasite infection, as observed in
Plasmodium vivax (19). To determine whether parasite localization in
the extravascular niche depends on specific parasite-host interactions,
we blocked endothelial receptors using antibodies against P-selectin,
E-selectin, ICAM-1, andVCAM-1 (vascular cell adhesionmolecule–1) or
a control antibody before merozoite infection into mice. Parasite bur-De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018den in BM was significantly decreased when specific receptors were
blocked individually or in combination, whereas circulating parasite
levels remained unaffected (Fig. 2, E and F, and fig. S2D). In particular,
gametocyte localization in the BM parenchyma was reduced by 60%
compared to control when host P-selectin was blocked. Together with
the predominant presence of gametocytes in CD44+ cells in the BM
parenchyma (Fig. 2C), these data may support a mechanistic model
where a subset of merozoites extravasates across the sinusoidal endothe-
lium via specific receptor-ligand interactions, reminiscent of homing and
vascular transmigration of immune cells (20). Increased levels of para-
site accumulation in BM including extravascular parasites in CD44−
cells were detected later during infection (figs. S2C and S3A), coin-
ciding with the emergence of vascular leakage in BM and spleen as a
result of inflammation (fig. S3B andmovie S1). Inspection of BM tissue
from P. falciparum–infected patients with fatal cerebral malaria revealed
the presence of significant levels of asexual parasites and gametocytes
in the BM parenchyma (Fig. 3, A to C). Together, these observations
suggest that acute infection facilitates further parasite infiltration of
the extravascular niche, including replicative asexual stages, through
vascular leakage.
Direct evidence for parasite translocation across
the BM endothelial barrier
Preferential accumulation of gametocytes in the extravascular niche, in-
cluding the parenchyma, suggests that mature gametocytes are capable
of crossing the endothelial barrier. Using a combination of transgenic
mice expressing endothelial markers and vascular staining revealed
multiple mature gametocyte translocation events (Fig. 4A and movies
S2 and S3) across the sinusoidal barrier of BM, spleen, and liver. Quan-
tification of individual translocation events in mice injected with equal
amounts of synchronized parasite stages revealed substantial crossing
events for gametocytes, whereas no events were detected for tropho-
zoites and schizonts (Fig. 4B). Characterization of transmigration
events showed significantly altered cellular diameter [that is, deforma-
tion index (21)] of mature gametocytes during transmigration,
whereas young parasites transmigrated with little measurable defor-
mation (Fig. 4C). This measure is approximate and limited by the res-
olutionpossible using intravitalmicroscopy (IVM).Taking this technical
limitation into account, gametocytes showed a deformation index of up
to 20-fold upon their passage through vessels both in the spleen and the
BMcompared to their uncompressed size.Gametocytes also displayed a
unique dextran permeability pattern during endothelial transmigration
compared to the other stages (Fig. 4, D and E, fig. S4, and movie S2),
suggesting amechanismof passage similar to highlymotile and deform-
able immune cells such as leukocytes during acute inflammation. Endo-
thelial transmigration of leukocytes requires actin-dependent motility
that can be inhibitedwith cytochalasinD (22), a potent inhibitor of actin
polymerization. Previouswork demonstrated that short-term treatment
of P. falciparum with cytochalasin D at 1 mMdepletes F-actin at the tip
of the polarized gametocyte (23) and inhibits the actin-dependent pro-
cess of merozoite invasion (24) without affecting viability. Here, we
showed that similar pretreatment of P. berghei gametocytes with cyto-
chalasin D before injection into Flk1-GFP reporter mice resulted in
>50% reduced extravascular gametocyte numbers. Furthermore, gameto-
cytes present in the extravascular space were located closer to vessels
compared to untreated parasites (Fig. 4F), perhaps suggesting impaired
mobility. Treatment of infectedmice over 3 dayswith sildenafil citrate,
a phosphodiesterase inhibitor known to keep P. falciparum gameto-
cytes in a rigid state (25), led to increased bioluminescent signal in the3 of 15
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 Fig. 2. Parasite homing and extravascular BM localization during mouse infection. (A) Synchronous infections of mice with mCherryHsp70-FLucef1a merozoites, rings,
trophozoites, schizonts, or gametocytes. Data show that merozoites, rings, and gametocytes are significantly enriched in BM and spleen (red arrows, ***P < 0.001) compared
to mean across all organs (dashed line). Data are expressed relative to parasite numbers quantified in the brain (normalized to 100) and correspond to intravascular and extra-
vascular compartments in all organs. (B) Representative diagram of hematopoietic development. Hematopoietic stem cells (HSCs) undergo a series of developmental steps until
formation of the final nucleated stage termed orthochromatic erythroblast (OCE), which upon enucleation gives rise to reticulocytes (Retic). Reticulocytes intravasate into circula-
tion and rapidlymature to terminal normocytes. Extravascular RBCprecursor cells aremarkedbyCD44,whereasCD71 is lost shortly after intravastion. (C) Presenceof stage-specific
reporter parasites in CD44+ RBCs following injection of merozoites. At 24 hpi, EG-CFP parasites, but not GNP-CFP and Con-CFP parasites, are largely confined to parenchyma and
sinusoidswheremost arepresent inCD44+RBCs (left panel), reflectingdistributionof CD44+ RBCs (mid left panel). Noparasites aredetected inCD44+ cells in peripheral blood (mid
right panel). Representative images of CD44+ cells in a BM section (magenta) are shown, upon injection of fluorescein isothiocyanate (FITC)–dextran (cyan) to mark vasculature
(top panel). Bottom image: Close-up of an infected CD44+ RBC in BM. (D) Presence of uninfected UBC-GFP RBCs in the BM extravascular niche. UBC-GFP RBCswere obtained from
transgenic donormice and injected into naïve, uninfected recipientmice andquantified in BM. A small proportion of RBCs accumulates in BMextravasculature butnot in the brain
extravascular niche (left panel). Representative image is shown (left) and a control with mCherryHsp70-FLucef1a P. berghei parasites (right). (E) Inhibition of parasite extravasation
using receptor antibodies. Micewere pretreated for 24 to 48 hours with P-selectin antibodies before injection ofmCherryHsp70-FLucef1amerozoites and compared to untreated and
nonviable (4% paraformaldehyde-fixed) control parasites (left panel). Parasite abundance in BM but not in brain or peripheral circulation is reduced upon P-selectin pretreatment
compared to controls. Injection of merozoites from stage-specific reporter parasites upon P-selectin pretreatment reveals greatest reduction in BM parenchyma with EG-CFP and
Con-CFPparasites,whereas intravascular localization is increased (right panel). Error bars represent SEs from five separate experiments in threemiceper condition. (F) Quantification
of peripheral parasitemia upon treatment with receptor antibodies. UBC-GFP mice were pretreated for 24 to 48 hours with P-selectin before injection of mCherryHsp70-FLucef1a
merozoites (right panel) and compared to untreated control parasites (left panel). Peripheral parasitemia and tissue burden were quantified before and after cardiac perfusion to
remove circulating parasites—leaving only those in the extravascular spaces. Extravascular parasite load decreases significantly in BM and spleen compared to control animals,
whereas peripheral parasitemia (obtained before perfusion) increases. P values are shown as **P < 0.05 and ***P < 0.005. All error bars represent SDs of the mean.De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018 4 of 15
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 BM and spleens of infected mice (Fig. 4G). These data support a
model where sildenafil citrate impedes the capacity ofmature gameto-
cytes to transmigrate; however, further work is required to fully char-
acterize this phenotype. Together, these observations provide initial
mechanistic insight and suggest that P. berghei gametocytes exhibit
some as yet uncharacterized mode of actin-dependent deformability
and/or mobility.
P. berghei gametocytes exhibit mobile behavior in the BM
Next, we systematically analyzed the behavior of different developmen-
tal gametocyte stages by intravital imaging. Monitoring gametocyte
maturation and in vivo behavior upon PH-S treatment of infected mice
revealed the presence of immature gametocytes in BM, spleen, and liver
(fig. S5A), whereas mature stages were detectable across all tissues.
As suggested by the gametocytes’ proximity to blood vessels after cyto-
chalasin D treatment (Fig. 4F), we observed that a significant fraction
ofmature gametocytes weremobile within the BM and spleen, both in
the intravascular and extravascular spaces. Others remained static in
the extravascular space or were circulating at the same speed as RBCs
in the intravascular space [Fig. 5, A to D, fig. S5B, movies S2 and S4
(mobile), and movies S5 to S12 (circulating/static)]. Parenchymal ve-
locity of mobile gametocytes ranged between 0.01 and 1.0 mm/s, where-
as no mobility was observed for uRBCs and those infected with asexual
parasites. In the sinusoids and small vessels, a fraction of mature gameto-
cytes was observed at speeds of 5 to 10 mm/s (Fig. 5B). These values are
very similar to the velocity reported for rolling leukocytes in these com-
partments (Fig. 5, B and C) (20). Overall, we defined three key charac-
teristics ofmature gametocytemobility: (i) it often requires contact with
other cells (Fig. 5, C and D), (ii) the lag time at each contact point is
more extended than that of asexual ring stage controls and reminiscent
of rolling leukocyte movement (Fig. 5D, right panel), and (iii) trans-
migration of mature gametocytes across vessels is not a rare eventDe Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018and individual gametocytes can transmigrate more than once (Fig.
5E). Suggestions of gametocyte mobility in vivo have never been re-
ported; however, recent studies on P. falciparum gametocyte cellular
structure have defined an architecture potentially compatible with mo-
tile “zoite” forms of the parasite such as sporozoites and ookinetes, al-
though gametocytes might use a different mode of movement, or the
movement observedmight be passive (23, 26). Both the patterns of mo-
bility and the contact-dependent movement in parenchyma and vessel
walls that we observed in our work have close similarities with the pro-
cess of rolling, adhesion, and transmigration characteristic of immune
cell types [reviewed in the studies of Vestweber (27), Nourshargh et al.
(28), Fackler and Grosse (29)]. Intravital images of leukocyte motility
are included in movie S13. Despite some similarities captured by mi-
croscopy, targetedmechanistic studies are required to determinewhether
the observedmobility is intrinsic to the gametocyte, whether it is a result
of overall movement of BM-resident cell populations through time, or
whether it represents peristaltic and heartbeat-induced movements (or
a mixture of all the above phenomena). Nevertheless, other P. berghei
stages, namely trophozoites, schizonts, and ring stages, do not display this
type of movement.DISCUSSION
P. falciparum gametocytes were first detected by Auguste Laveran in
the 1880s; however, major knowledge gaps in their biology still exist.
Marchiafava and Bignami (2) initially detected gametocytes in autopsy
material and hypothesized their sequestration in tissue niches. Addi-
tional historical case studies of malaria patients have indicated presence
of the human malaria parasite P. falciparum in BM and spleen (3, 4).
Our systematic investigation in a cohort of fatal pediatric malaria cases
has demonstrated significant enrichment of transmission stages in the
BM extravascular niche (6). Parallel comparative investigation of BMFig. 3. Asexual and gametocyte stages in the BM parenchyma of human malaria cases. (A) NanoString analysis of BM, brain, and heart tissue from patients who died of
clinical cerebral malaria. Asexual P. falciparum parasite stages are predominantly sequestered in the brain and heart (left panel). All gametocyte-specific transcripts are sig-
nificantly enriched in BM compared to the other tissues (right panel). Data were normalized on the basis of background subtraction and expression of housekeeping genes.
**P < 0.01 and ***P < 0.001. (B and C) Quantification of immunohistochemistry (IHC) studies on human autopsy cases from BM tissue (n = 22). (B) Quantification of IHC with
KAHRP antibodies to mark asexual P. falciparum parasites and CD31 to mark vasculature (HPF, high-powered fields). Histogram demonstrated that presence of parasites in BM
is highest in the parenchyma compared to sinusoids and vessels. (C) Patients succumbing in absence of cerebral malaria (CM) had higher numbers of gametocytes (Pfs16) in
parenchyma than asexual parasites (KAHRP), whereas these numbers were similar in CM patients. Representative IHC images of CD31 (brown) and KAHRP (red) from a human
autopsy BM sample are shown. Arrows indicate intravascular asexual parasites, and arrow heads indicate extravascular asexual parasites. *P < 0.05. Scale bars, 20 mm.5 of 15
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 Fig. 4. Gametocyte transmigration dynamics and vascular leakage. (A) Time series of mCherryHsp70-FLucef1a gametocyte crossing the vascular endothelium in an Flk1-
GFP (top panel) or UBC-GFP (bottom panel) transgenic mouse. [Time lapse, 5 frames/s; scale bar, 10 mm.] P, parasite; IV, intravascular; EV, extravascular; C1,2, contact site; T1,2,
transmigration. In the top panel series, a gametocyte is exiting the BM vasculature (marked as dotted lines), whereas the bottom panel series are showing a gametocyte
entering the BM vasculature. (B) Quantification of observed transmigration events across the BM vascular barrier. Upon injection of synchronized parasite stages, only
merozoites and gametocytes show significant levels of transmigration events. (C) Sphericity and deformability of P. berghei parasites. Left: Representative in vivo images
across stages ofmCherryHsp70-FLucef1a parasites within UBC-GFP RBCs in static and flow conditions (scale bar, 5 mm). Right: Deformability indices across stages defined as the ratio
of maximum cellular diameter before (static) and during (contracted) transmigration (n = 100; bars represent mean, and error bars represent SD. ***P < 0.001). (D and E) Trans-
migration and vascular leakage. Mice are injected with synchronous mCherryHsp70-FLucef1a parasite stages followed by FITC-dextran inoculation, and images are taken at a
rate of 5 fps. Representative images of FITC-dextran fluorescence intensity are shown (D). Quantification of FITC-dextran leakage (representative of peripheral blood
including iRBCs and uRBCs), demonstrating a unique transient leakage pattern upon injection of mature gametocytes (E). Note that merozoites/rings (M/R) values are normalized
by schizont valuesbecauseof theobserved low levelof sustained leakagepattern likely causedbyco-injectedhemozoin.MFI,mean fluorescence intensity. (F)Gametocyte treatmentwith
CytochalasinD (C.D.) abrogates extravascular accumulation.mCherryHsp70-FLucef1a gametocytes are purified ex vivo and incubatedwith C.D. (or vehicle control) beforewashout and
intravenous injection into naïvemice. Relative abundance and distance from vessels in the extravascular BM compartment are significantly reduced. IVS, intravascular space; EVS,
extravascular space. (G) Treatment of infectedmicewith sildenafil citrate results in gametocyte accumulation in BM and spleen. Mice treated with phenylhydrazine were infected
with mCherryHsp70-FLucef1a parasites and treated with sulfadiazine–sildenafil citrate for 3 days (or sulfadiazine only, control). Treatment leads to significantly increased accumu-
lation of gametocytes in the BM and spleen of mice compared to control. In all panels, error bars represent SDs of the mean. *** P < 0.001 and **P < 0.01. N.A., not applicable.De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018 6 of 15
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 Fig. 5. Gametocytes display mobility behavior in tissues of the reticuloendothelial system. (A) Gametocytes are mobile in the BM and spleen. Early (EG) andmature (MG)
gametocyte behavior is quantified across intravascular and extravascular compartments. Most mobile gametocytes are mature; most of the mature gametocytes are found
passively circulating in the vasculature, whereas a subset is present in all compartments. Early gametocytes are confined to the extravascular niche and static. (B) Mature game-
tocytes move at speeds between 0.01 and 1 mm/s in the parenchyma of BM, similar to leukocytes. A subset of gametocytes and leukocytes (black box) show contact-dependent
movements in the sinusoids and small vessels of the same organs at a speed between 4 and 10 mm/s. In contrast, uninfected erythrocytes and asexual parasite stages are static in
the parenchyma and passivelymovewith the flow in sinusoids and small vessels at amuch higher speed. (C andD) Time-lapse intravital images of gametocyte behavior in the BMor
spleen. P. bergheimCherry gametocytes are imaged in Flk1-GFPmice. Toppanel:Maturegametocyte circulatingwithin the vasculature (arrow). Secondpanel:Mobile (arrow) and static
(arrow head) gametocytes in the BM extravascular space of Flk1-GFPmice. Third panel: Motile behavior of leukocytes in uninfected UBC-GFPmice. Bottom panel: Mobile behavior of
gametocytes in infectedUBC-GFPmice. (D)Mobility pattern of onegametocytedynamicallymoving in theBM.Mature gametocytes showmultiplemobility patterns in the spleen and
BM:multiple contact points in parenchyma (represented by 0 in the y axis) followed by forwardmotion (left panel) and rapid translocation upon contact with sinusoidal endothelium.
Compared to ring stages, gametocytes contact theparenchyma two to four timesmore frequently (middle panel). At every contact point leading to a stopphase, gametocytes display a
lag in velocity of up to 35 s (right panel). (Graphs showmedian and interquartile ranges of lag time following contact.) Error bars showSEM. ***P<0.001. (E)Maturegametocytes display
various behaviors in relation to crossing the vascular endothelium.Most of the parasites recordedwere in the vasculature and not crossing, whereas a subset is either crossing once
or twice. (F) Hypothesizedmodel of parasite dynamics in the BM. (I) Distribution of Plasmodiumgametocyte stages in the BM. Early gametocyte stages accumulate in the parenchyma
and sinusoids of BM (and spleen), whereasmature gametocytes are found both intra- and extravascularly. (II) Vascular leakage and its relation to asexual parasite accumulation in BM.
Disease progression coincides with vascular leakage in sinusoids of the reticuloendothelial system but not in the vasculature of other tissues. This leakage results in increased
accumulation and replication of asexual parasite stages in the BM parenchyma. (III) Mobility and vascular migration in the BM. A subset of merozoites, including most of the
sexual merozoites, invades BM-resident RBC precursor cells in sinusoids and parenchyma. The latter requires merozoite extravasation across the sinusoidal barrier via specific
receptor-ligand interactions. Early gametocytes are located on the sinusoidal lining and attached to erythroblastic islands in the parenchyma, where they develop until maturity
(represented by red arrow). Mature gametocytes become mobile, presumably coinciding with a switch in deformability, and enter circulation from their extravascular niche.De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018 7 of 15
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 aspirates and peripheral blood samples from anemic children revealed
immature gametocyte enrichment in the BM niche (7). Finally, recent
data in humanizedmice demonstrated some gametocyte enrichment in
BM (16). The biological relevance of these observations remained un-
clear and represents one of the key knowledge gaps in the parasite cycle.
Here, we have used a series of complementary approaches to demon-
strate extravascular parasite development in the rodentmalaria parasite
P. berghei. In contrast to human biopsy cases and the highly artificial
humanized mouse model, the establishment of a solid rodent model
to study the dynamics of gametocyte homing to the different tissues de-
pending on its developmental stage opens completely new roads for the
research on sexual Plasmodium stages.
We demonstrate here that preferential gametocyte development in
the BM and spleen extravascular niche is present in the rodent malaria
model, suggesting conservation of this phenotype across Plasmodium
lineages. We provide conclusive evidence for the selective and receptor-
mediated homing of a subset of merozoites to the BMwhere they initiate
extravascular parasite development upon invasion of RBC precursor
cells. These observations suggest the existence of distinctmerozoite pop-
ulations: sexual merozoites with restriction (or at least strong preference)
for BM and spleen homing and extravasation and asexual merozoites
with no such tissue restriction. We hypothesize that sexual merozoites
display a set of unique surface ligands that provide the selectivity for in-
teractions with BM and spleen endothelial receptors such as P-selectin,
in addition to those required for RBC invasion.We also detected asexual
parasite stages in the extravascular environment both in P. falciparum
(in human autopsies) and inP. berghei (in infectedmice), suggesting the
existence of a genuine extravascular asexual cycle in both Plasmodium
lineages. If confirmed, then such an extravascular replication cycle may
represent a parasite reservoir independent of the major asexual parasite
population in the vasculature, with possible implications for diagnosis
and treatment.
Intravital imaging experiments in infected mice provide direct evi-
dence for transmigration across the endothelial barrier and yet unchar-
acterizedmodes ofmature gametocytemobility in the extravascular and
intravascular environments of BM and spleen, both characteristics of
immune cells such as leukocytes. Specifically, we observed highly de-
formable mature gametocytes crossing the endothelial barrier in both
directions. A series of studies in P. falciparum have demonstrated that
immature gametocytes are rigid before switching to a deformable state
during final maturation (26, 30, 31). This deformability switch involves
a adenosine 3′,5′-monophosphate–dependent signaling cascade that
can be blocked with specific inhibitors such as sildenafil citrate (25).
Here, we demonstrate that sildenafil citrate accumulates gametocytes
in BM (and spleen), suggesting that the switch to a deformable state
is required for the intravasation of mature gametocytes into circulation
(and subsequent passage through the spleen). Further experiments are
required to rigorously test this hypothesis in the animalmodel and under
controlled in vitro conditions.We also observed thatmature gametocytes
were changing location in the parenchyma at speeds similar to leukocytes
(~0.5 mm/s), whereas asexual parasites and uRBCs remained static. Simi-
larly, a subset ofmature gametocytes displayed contact-dependentmove-
ments in sinusoids and vasculature similar to leukocytes (5 mm/s). The
observed restriction of these phenotypes to BM and spleen suggests that
a specific microenvironment is required to induce gametocytemobility.
Intriguingly, our experiments also revealed thatmature gametocyte homing
to BM and their extravasation are inhibited by the actin-depolymerizing
agent cytochalasin D. Together, our data suggest that mature gameto-
cyte mobility displays many hallmarks of immune cells. Given that ga-De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018metocytes are intracellular, they must provide machinery to a host
cell that otherwise is incapable of the observed phenotypes. Notably,
RBCprecursor cells reach the endothelial barrier and intravasate during
their maturation. Our data demonstrate that gametocyte development
is largely restricted to these RBC precursors because of their predomi-
nance in the extravascular environment, and therefore, gametocytes may
modify their young host cell to ensure that it retains these properties.
Our hypothesized model for gametocyte dynamics based on the
findings of this work is summarized in Fig. 5F. These findings define
the BM as a key compartment in the Plasmodium life cycle, with major
implications for our understanding of parasite biology, diagnosis, and
the development of novel transmission-blocking interventions.MATERIALS AND METHODS
Study design
Given our previous evidence in human autopsy case studies of enrich-
ment of Plasmodium parasites in the BM and spleen (6), we aimed to
investigate the distribution of asexual parasites in BM tissues using
stage-specific antibodies. For this purpose, we analyzed the same subset
of autopsy samples that were used for the initial investigation of BM
enrichment in our original study.
In a second line of investigation, we aimed to define presence and
dynamics of parasites in rodentmodels. To do this, we established IVM
methods and rigorously quantified parasites by fluorescence micros-
copy in vivo and ex vivo in all organs as stated. Each experiment was
performed at least in triplicate, with five mice per repeat, per group
and/or per condition.Weperformedpower analyses to calculate sample
sizes. In specific experiments where the number of events in 15 mice
was not sufficient to reach this power, we increased the number of mice
used. The rule that we adopted to stop data collection was the develop-
ment of cerebral malaria symptoms in C57BL/6, UBC-GFP C57BL/6,
or FLK-GFP C57BL/6mice; however, most of thesemice were not used
to measure parasite loads at the time window or parasitemia numbers
where experimental cerebral malaria is expected. We did not exclude
any outlier. The research subjects in all cases were either C57BL/6 mice
[wild-type (WT) or fluorescent reportermice] or Balb/cmice.P. berghei
ANKAparasites were used throughout the study. Treatments applied to
the animals included infections, drug treatments, dye injections to visu-
alize the vasculature, and antibody treatments. The outcomes of infec-
tion were quantified by luminescence or fluorescence in vivo by IVMor
bioluminescence imaging, or ex vivo following organ extraction, using
confocal microscopy or bioluminescence imaging. Animals were ran-
domly divided into cages of the different experimental groups, and ani-
mals of the same age and batch (often siblings) were selected each time
for the various assays. Blinding was performed at stages where this was
possible; however, not all treatments or interventions were blinded.
Patient samples and ethical approval
Patient samples used in this study were from autopsies performed as
part of the pediatric severe malaria postmortem study conducted be-
tween 1996 and 2011, and the patient demographic information and
sample collection procedure were previously described (6). The autopsy
cohort study was approved by the institutional review boards at the
University of Malawi College of Medicine, Michigan State University,
andHarvard T.H. Chan School of PublicHealth. Informedwritten con-
sent was obtained from all parents/guardians of the enrolled patients.
Criteria used for diagnosis and clinicalmanagement have been previously
described (32). More than 2000 individuals were enrolled throughout8 of 15
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 the duration of this study, and the mortality rate for the study partic-
ipants was between 15 and 20%. Consent was given to conduct an au-
topsy for 103 cases, and these autopsies were performed between 2 and
14 hours after death.
Selection of samples from autopsy study
For this study, the same human samples previously used by Joice et al.
(6) for assessment of sites of gametocyte enrichment were analyzed. In
summary, out of 103 samples, samples from HIV-positive individuals
and individuals of unknown HIV status were excluded (27% of enrol-
lees). For the remaining samples, only those for which all nine tissues
were available (that is, spleen, heart, brain, lung, liver, BM, gut, kidney,
and subcutaneous fat)were assessed. Further filters included a postmortem
time before fixation greater than 12 hours (resulting in poor structural
preservation of tissue samples) and availability of BM formalin-fixed,
paraffin-embedded blocks. This resulted in the selection of a subset of
36 samples. Six were excluded because of lack of CD31 labeling by IHC
in the BM sections. From the remaining 30 samples, 22 specimens were
selected on the basis of the presence of at least two Plasmodium lactate
dehydrogenase–labeled parasites per 50 high-power fields in the CD31
analysis.
Optimization and controls for histological assays
in human tissues
To determine antibody specificity for the parasite stages of interest, we
generated formalin-fixed and paraffin-embedded mock tissue samples
containing cultured RBCs infected with asexual and sexual P. falciparum
parasite stages. Briefly, 100ml of packedRBCs, derived either fromasexual
cultures or from individual time points of gametocyte development time
courses, were mixed with thrombin 2 and fetal bovine plasma, wrapped
in lens paper, and fixed with formalin. Cell clots were then placed into
a paraffin wax block with a composite of surgical tissue specimens ob-
tained from the Brigham andWomen’s Hospital (Boston) for BMs that
were analyzed in the autopsy study and sliced at a thickness of 3 mm.
Using these samples, parasite antibodies and host antibodies were ti-
trated for specificity and against host tissue background labeling.
IHC assays of human autopsy material
Formalin-fixed and paraffin-embedded tissues and control blocks were
cut into 3-mmsections andmounted on slides. Sectionswere dried over-
night at 37°C and then processed through deparaffinization in xylene
and subsequently hydrated through a series of graded ethanol (100 to
50%), finishing in water. Antigen retrieval was performed by incubating
slides at approximately 95°C in a steamer for 30 min using 1× Antigen
Retrieval Reagent Universal (R&D Systems). Following antigen retriev-
al, slides were blocked using a universal blocking buffer (Thermo Fisher
Scientific) for 20 min, followed by 10 min each of avidin- and biotin-
blocking buffers (Invitrogen) to block endogenous biotin and avidin,
respectively.Antibody incubation [mouse anti-KAHRP(Knob-associated
histidine rich protein) combined with rabbit anti-CD31] was then per-
formed overnight at 4°C diluted in blocking buffer (1:100, 1:100, and
1:20 dilutions, respectively, in universal blocking buffer). Wash steps
in between each step thereafter were performed with tris-buffered
saline+5%Tween for 3×5min.A secondary goat anti-rabbit horseradish
peroxidase–conjugated and a biotin conjugate of the F(ab′)2 fragment
of goat anti-mouse immunoglobulin G (IgG) (H + L) antibodies were
used (Invitrogen) (diluted to 1:500 in universal blocking buffer),
followed by streptavidin conjugated to alkaline phosphatase (Thermo
Fisher Scientific) (diluted 1:3000 in universal blocking buffer). For theDe Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018development of signal, a Fast Red 4 TR/Naphthol AS-MX substrate re-
agent (Sigma-Aldrich) was applied. Slides were subsequently rinsed in
water and counterstained in Mayer’s hematoxylin and mounted in
aqueous mounting medium. Slides were blinded to patient identifica-
tion (ID), and parasites were counted in 100 consecutive high power
fields, starting in the upper left corner of each section.
NanoString expression arrays of human autopsy material
RNA extraction
RNA frompatient tissue samples stored in RNAlaterwas extracted using
the Qiagen RNeasy Plus Mini kit (Qiagen). Briefly, tissue samples were
homogenized in the Qiagen RLT Lysis Buffer (Qiagen) and processed
using the PolytronHomogenizer (Kinematica). The homogenized lysate
was passed through genomicDNAeliminator columns (Qiagen), subse-
quently applied toRNeasy spincolumns, followedby severalwashesaccord-
ing to themanufacturer’s instructions and eluted in nuclease-free water.
NanoString analysis
The nCounter custom code set was designed for P. falciparum that in-
cluded differentially expressed genes to distinguish specific stages includ-
ing asexual parasites (circulating rings and sequestrating trophozoites/
schizonts) and sexual stages (gametocyte rings and immature and ma-
ture gametocytes) as defined from our previous transcriptional network
analysis study (33). In total, there are 161 genes representing asexual
circulating stages, 147 genes representing asexual sequestering stages,
26 genes representing gametocyte rings, 27 immature gametocytes,
and 29 mature gametocyte genes. The remaining set was not annotated
for any of these stages. A total of 456 genes were included in this custom
probe set including housekeeping genes. For NanoString analysis of tis-
sue samples, 500 ng of purified total RNAwas used as input. Briefly, RNA
from each sample was allowed to hybridize with reporter and capture
probe set at 65°C for 20 hours according to the nCounter gene expression
assay protocol (NanoString Technologies). After several washes in the
preparation, RNA-probe complexes were immobilized to nCounter car-
tridge followed by scanning in the nCounter Digital Analyzer. Data were
normalized on the basis of background subtraction, and expression
of housekeeping genes using nSolver Analysis software (NanoString
Technologies) according to guidelines and statistical analysis was
performed. The normalized data were included in table S1.
Animals and ethics statement
Animal studies were carried out under the approval of the Animal Re-
search Ethics Committee of the Canton of Bern, Switzerland (permit
numbers 91/11, 81/11, and BE60/17), the University of Bern Animal Care
and Use Committee, and the UKHome Office (permit number 60/4443).
For all studies, Balb/c, C57BL/6, UBC-GFP C57BL/6, Flk-GFP C57BL/6,
and Lys-GFPC57BL/6 females 5 to 12 weeks of age, weighing 25 to 30 g
at the time of infection were used. Mice were bred in the central animal
facility of the University of Bern or supplied by Harlan Laboratories or
Envigo Laboratories. Blood feeding to mosquitoes was performed
under Ketasol/Dorbene anesthesia. Luminescence imaging was per-
formed under isofluorane anesthesia, and intravital imaging was per-
formed under xylazine/Ketasol/isofluorane anesthesia, and all efforts
were made to minimize suffering.
P. berghei lines used
Various P. berghei ANKA lines were used to infect mice. Lines used in
this study included Pb mCherryHsp70, constitutively expressing mCherry
in theparasite cytosol (34); a transgenic line expressingNanoLuc luciferase
and mCherry under constitutive promoters (Pb mCherryHsp70NLucef1a)9 of 15
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 (35); a transgenic line expressing firefly luciferase and mCherry under
constitutivepromotersPbmCherryHsp70FLucef1a (36); and thenonseques-
teringP. berghei linePbDSBP1-GFP-mCherryHsp70FLucef1a (9). In addition,
P.berghei linesG623(820)andG629(GNPm9),withCFPexpressionunder
the PBANKA_101870 promoter, and lines G488 (820), G458 (GNPm9),
and G455(HP), with CFP expression under the Hsp70 promoter were
used to investigate differences in parasite localization among previously
published gametocyte-producing and gametocyte-nonproducing lines
(15). Lines G629 (GNPm9) andG455(HP) were used for normalization
purposes. Subclones of the above lines were generated by detached cell
injection, as previously described (37).
Induction of gametocytemia
To enhance parasitemia and simultaneously induce gametocytemia
early after infection as previously published (8), erythropoiesis was
stimulated by the intraperitoneal injection of 200 ml of a solution of
phenylhydrazine in saline (6 mg/ml). Mice were infected (intraperi-
toneally) with 105 Pb ANKA-mCherryHsp70, G623, G629, G488, or
G458 parasites 2 days later. Blood smearsweremade daily and checked
both by fluorescence andWright staining. Upon reaching 5 to 10%par-
asitemia, to suppress proliferation of asexual stage parasites, mice re-
ceived sulfadiazine (10 mg/liter) in their drinking water (from days 3
to 4) after infection onward. Sulfadiazine treatment led to elimina-
tion of asexual populations. Because gametocytemia decreases also af-
ter 4 or more days of sulfadiazine treatment, IVM, bioluminescence, or
collection of infected blood for the purification and passage of gameto-
cytes was routinely performed after 3 to 4 days of treatment (that is, 6 to
7 days after infection).
Parasite maintenance in mosquitoes
Balb/c mice were treated with phenylhydrazine 3 days before intraperi-
toneal infectionwith the differentP. berghei lines. After 3 days of infection,
parasites were spotted on a coverslip, and exflagellation was determined.
The infectedmice were then used to feed 100 to 150Anopheles stephensi
female mosquitoes each. Mice were anesthetized with a combination of
Ketasol (125 mg/kg) and Dorbene (12.5 mg/kg) anesthesia and eutha-
nized with CO2 after completion of the feed. Afterward, mosquitoes
were fed until use with 8% fructose and 0.2% para-aminobenzoic acid.
Sporozoites used for mice infection were isolated from the mosquitos’
salivary glands at day 18 after infection.
Mouse infection with P. berghei sporozoites
For bioluminescence imaging of liver stage development, 106 P. berghei
sporozoites were collected from salivary glands of infected A. stephensi
mosquitoes and injected intravenously into female Balb/c mice 6 to
12 weeks of age. Liver stage infections were monitored by biolumines-
cence until egress was detected.
Mouse infection with P. berghei synchronous stages
To generate and purify schizonts and establish synchronous infections,
a previously published protocol for schizont transfection was followed
(38). In summary, two naïve Balb/c mice were injected with 200 ml of a
P. berghei stabilate. Upon reaching a parasitemia of up to 5% (usually at
days 4 to 5 after infection, verified by Wright staining), blood was col-
lected by intracardiac puncture. Complete RPMI1640 culture medium
(125 ml) was prepared by adding 25 ml of freshly thawed fetal bovine
serum to 100ml of RPMI1640 culturemedium and 200 ml of gentamicin
stock solution. Between 15:00 and 18:00, a total of 1.5 to 2 ml of infected
blood was collected from each of the two mice by cardiac punctureDe Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018following euthanasia by CO2 inhalation. The blood was immediately
added to a 50-ml Falcon tube containing 5 ml of complete media sup-
plemented with 350 ml of heparin stock solution. Infected erythrocytes
were then harvested by centrifugation for 8 min at 450g, and the super-
natant was carefully discarded. The iRBCswere resuspended in 50ml of
complete media and mixed with the 120 ml of RPMI1640 complete
media. The total volume was divided equally between two tubes/flasks,
each containing around 85 ml. The tubes/flasks were gassed for 90 s at
1.5 to 2 bar pressure with the gas mixture of 5%CO2, 5%O2, and 90%
N2. Tubes were closed tightly following gassing and placed immedi-
ately at a 37°C shaking/rotating incubator. The parasites were incubated
overnight for 16 hours, and viable schizonts were collected between
9:00 and 12:00 of the following morning as follows. First, 500 ml of
the schizonts inmediawas collected and centrifuged for 5min at 16,000g.
The supernatant was discarded, and a blood smear was prepared and
stained with Wright stain. The smear was verified by light microscopy
for contamination and schizont enrichment. Before schizont isolation,
a 55% Nycodenz–1× phosphate-buffered saline (PBS) solution (v/v)
was prepared in a 50-ml Falcon tube by adding 27.5 ml of Nycodenz so-
lution [138 g of Nycodenz powder dissolved in 500ml of 5mM tris/HCl,
3 mMKCl, and 0.3 mM CaNa2-EDTA in deionized water (dH2O) at
pH 7.5] to 22.5 ml of 1× PBS. Schizont cultures (170 ml) were divided
into four separate 50-ml Falcon tubes (each containing 25 to 30 ml).
Using a 20-ml pipette, 10 ml of Nycodenz-PBS solution was under-
played under the culture suspension in each tube. All tubes were cen-
trifuged for 20min at 450g in a swing-out rotor at room temperature,
without brake or initial acceleration. After 20 min, using a Pasteur
pipette, the brown-grayish interface of schizonts between the two sus-
pensions was collected from each tube. The isolate (10 ml) was Hoechst-
stained, and schizont purity and number per volume were quantified.
Aliquots of 6 × 106 schizont were separated into Eppendorf tubes, cen-
trifuged for 5min at 450g, resuspended in 200 ml of 1× PBS, and injected
intravenously into naïveUBC-GFPC57BL/6 orWTC57BL/6mice.De-
pending on the time when schizont purification was initiated, injection
intomiceoccurredbetween10:00 and13:00.At all consecutive times,mice
were kept in a strict 12-hour light cycle to keep parasite synchronicity.
Schizont localization in the recipient mice’s bodies (by biolumines-
cence imaging) or in theBMs (by IVM)was performed at 22 to 24 hours
after infection. For isolation of merozoites, rings, and trophozoites, the
mice infected with schizonts were regarded as intermediate donor mice
andwere bled by intracardiac puncture at 4 hours after infection for iso-
lation of rings and at 11 hours after infection for isolation of trophozoites.
Upon obtaining 1.5 to 2 ml of synchronously infected blood, a Percoll
density gradient was used to separate the corresponding parasite stages.
Pure rings or pure trophozoites were resuspended in 200 ml of 1× PBS
and intravenously injected into naïveUBC-GFPC57BL/6 orWTC57BL/6
mice.Micewere imaged 2 hours after infection. Formerozoite injection,
isolated schizonts were mechanically ruptured, and merozoites were
briefly incubated in 100 ml of heparin, followed by intravenous injection
into naïve UBC-GFP C57BL/6 orWTC57BL/6mice. Mice were imaged
by IVM or bioluminescence immediately following injections.
Bioluminescence in vivo and organ ex vivo imaging
Plasmodium localization was imaged using luciferase-expressing Pb
mCherryHsp70FLucef1a parasites and gene-deletion mutants PbDSBP1-
GFP-mCherryHsp70FLucef1a, in a bioluminescence in vivo imaging system
(IVIS 100; Caliper Life Sciences—f/stop, 1; no optical filter, or IVIS-
Spectrum;Caliper Life Sciences—f/stop, 1; no optical filter) both, in vivo
(3-min exposure; 10-min postsubstrate injection; 8 binning; 12.5-cm10 of 15
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 field view) and ex vivo (30-s exposure; 3-min postsubstrate injection;
8 binning; 10-cm field view). Camera temperature for acquisition was
−90°C, and stage temperature during acquisition was 37°C. Biolumi-
nescent images in Balb/c and C57BL/6 mice were obtained at 65 hours
after sporozoite intravenous injection, at 22 to 24 hours after infection
with synchronous schizonts, at 7 days after intravenous injection of 105
schizonts, and following treatment ofmice with phenylhydrazine (2 days
before infection) and sulfadiazine (3 days after infection) (treatment de-
scribed in detail below). Luminescence levelswere normalized to schizont
levels detected in the brains of controlmice. Synchronized infectionswere
established by schizont purification, isolation, and injection as previous-
ly described.Mice were anesthetized using 2.5% isofluorane, and 100ml
of the substrate RediJect (30 mg/ml; PerkinElmer, 760504) was injected
intraperitoneally. Following whole-body imaging, mice were eutha-
nized and perfused with 1× PBS to remove unbound parasites. Individ-
ual organs including the lungs, heart, liver, adipose tissue, BM, kidneys,
brain, and spleen were removed from infected mice following perfu-
sion. Acquired data were analyzed using the program Living Image
4.4. Experiments were repeated a minimum of three times, with five
mice per repeat.
Intravital imaging of solid organs
Intravital imaging was performed in 5- to 8-week-old female UBC-
GFP C57BL/6 mice, Lys-GFP C57BL/6 mice, Flk1-GFP mice, vascular
endothelial-cadherin-GFP mice, WT C57BL/6 mice, and WT Balb/c
mice infected with Pb-mCherryHsp70 parasites using synchronous
stages (that is, schizonts, merozoites, trophozoites, and gametocytes).
Three parasite doses were injected for all experiments involving syn-
chronous infections: an initial inoculum of 105, 106, or 6 × 106. A mix-
ture of anesthetics comprising ketamine (125 mg/kg; Ketasol, Graeub)
and xylazine (12.5mg/kg; Xylasol, Graeub), was prepared and diluted in
1× PBS (1:2:5). Mice were injected intraperitoneally with 100 ml per
20 g of body weight, of the mixed anesthetic, and injections were re-
peated periodically during imaging. In the case of solid organs, the
surgical procedure involved a small incision to expose the spleen, kid-
ney, liver, or adipose tissue. The exposed tissues were glued to a micro-
scope cover glass (VWR24, 50mm, no.1) and imagedwith a Zeiss LSM5
live scanning module, a Leica SP8-STED confocal microscope, or a
Andromeda confocal Spinning Disc microscope with Yanus laser scan
head, from Till Photonics. In each microscope, imaging was performed
using a Plan Apochromat 63× 1.4 numerical aperture (NA) DIC M27
oil immersion objective (LSM5), an HC PL APO CS2 63× 1.4 NA or
100× oil immersion objective (SP8-STED), or a 60× 1.4 NA oil immer-
sion objective from Olympus. All microscopes were equipped with a
temperature chamber to enable controlling themice’s body temperature
following anesthesia during image acquisition. In the Zeiss LSM5 con-
focal microscope, imaging was performed with 0.1 mW from a 489-nm
light from a diode laser to excite GFP, whereas 2 mW from a 561-nm
diode pumped solid-state laser was used to excite mCherry. Simultaneous,
rather than sequential, excitation was used to ensure high-speed image
acquisition. In the Leica SP8-STEDmicroscope, a white laser was used,
and wavelengths were defined for the respective spectra of GFP and
mCherry. As above, 512 × 512 fields of view were acquired, at speed 4,
zoom 10 to 40, and pinhole 1.0. For fast image acquisition, dual fluores-
cence was simultaneously acquired using an 8000-Hz resonant scanner
with 30 times frame averaging. In the Andromeda confocal spinning
disc system, GFP was excited with a 488-nm laser, and mCherry was
excited with a 561-nm laser. Between 50 and 100 different fields of view
were selected in eachmouseorgan, and imageswere acquired every 500msDe Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018for 5 min. Experiments were done in triplicate mice for each synchro-
nous parasite stage, each day after infection (that is, 2 hours, days 1 to 7),
and the different initial infectious inocula (that is, 105, 106, or 6 × 106).
Line scans were positioned at various depths of the vessel, and video-
rate imaging was used to record blood and parasite flow in P. berghei–
infected mice. The recorded movies were assembled and processed
using Fiji software (http://fiji.sc/Fiji).
Intravital imaging of the BM: Calvarium and tibia
ForBMIVM, two siteswere selected for imaging, namely, the calvarium
(skull) and the tibia (leg), to assess potential differences in BM in long
bones versus other bone structures. For analysis of the BM in the cal-
varium, following anesthesia, an incision was made in the skin overlay-
ing the head, within a distance from the eyes to the base of the ears. This
resulted in exposure of the skull, which was subsequently mechanically
thinned. Measurements in the BM were made between the sagittal su-
ture bifurcation and the intersection of sagittal and coronal sutures.
Image postprocessing and analysis were performed using the Fiji soft-
ware. For IVM of the tibia, mice were prepared as previously published
(39). In summary, the tibia was exposed by removing the skin on top
of the leg, followed by removal of the muscle with a scalpel. The bone
was thenmechanically thinned. An SP8-STEDmicroscope, or an LSM5
microscope with the features previously described, was used for imag-
ing, and a special mouse holder for the microscope stage was especially
designed for this purpose usingTopSolid, aCAD/CAM(computer-aided
design/computer-aided manufacturing) system. This model was later
three dimensionally (3D) printed for use at the SP8-STEDmicroscope.
Imaging of CFP reporter lines using a SP8-STED microscope
P. berghei lines used in this study express CFP,GFP, ormCherry report-
ers for detection of parasites. When these lines were used in combina-
tion with A647markers to indicate other parameters within the mouse,
choice of wavelengths was optimized on the white-laser SP8-STED (fig.
S1E). The colors were imaged sequentially, with sequence 1 covering
wavelengths 432 to 499 including the excitation maximum of CFP,
andmeasuredwith a 405-nm laser and aHyDdetector for sensitive im-
aging. Sequence 2 covered wavelengths 500 to 562 including the excita-
tionmaximumofGFP andmeasured using a 488-nm laser and a (PMT)
detector. Sequence 3 covered wavelengths 563 to 657 including the exci-
tation maximum of mCherry and measured using a 587-nm laser and
a HyD detector. Sequence 4 covered wavelengths 658 to 779, including
the maximum of A647, measured using a 653-nm laser and either a
HyD or a PMT detector. Imaging ex vivo was done using unidirectional
scanning (Galvo scan), a line average of 5, a pinhole of 1.0 AU (Airy
units), and varying degrees of zoom. Imaging by IVM was done using
the resonance scanner mode, with bidirectional scanning at a rate of
5 frames/s, a pinhole of 3.59 AU, and a line averaging of 5 to 8.
Assessment of vascular leakage
To visualize the bloodstream, 5mg of 70-kDa FITC-conjugated dextran
(Sigma-Aldrich) and 5 mg of FITC-albumin (Sigma-Aldrich) dissolved
in 500 ml of PBS were injected intravenously in the tail vein of an anes-
thetizedmouse. Stacks of 30 images, spaced 1 mmapart, were acquired
every minute for volumetric imaging. In addition, time-lapse imaging
was acquired as above, that is, between 50 and 100 different fields of view
were selected in each mouse organ, and images were acquired every
500 ms for 5 min. FITC was also imaged ex vivo in excised organs. Flu-
orescence intensity of FITCwithin and outside the vascular cavities was
measured using Fiji.11 of 15
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of the vascular endothelium
To investigate the effects of blocking various molecules present in the
vascular endothelium, antibodies used included the following: RB40.34
(rat IgG1, 30 mg per mouse; BD Biosciences, catalog no. 553742), a mono-
clonal antibody (mAb) againstmurine P-selectin and 9A9 (rat IgG1, 30 mg
permouse), a mAb against murine E-selectin (provided by K. Ley, La Jolla
Institute for Allergy and Immunology) or alternatively a mAb against
murine E-selectin (rat IgG1, clone 96419, 30 mg per mouse; R&D Sys-
tems no. MAB5751-100). A 1:1 combination of P- and E-selectin anti-
bodies was also used. Likewise, rat mAbs YN1/1.7.4 directed against
ICAM-1 (50 mg permouse, Abcam no. ab25375), rat mAbMK2 directed
againstVCAM-1 (50 mg permouse, Abcamno. ab19569), or a 1:1 combina-
tion of YN1 andMK2were used. Antibodies were injected intravenously
(E-selectin and P-selectin) or intraperitoneally (all other antibodies) for
two consecutive days before injection of purified schizonts/merozoites.
Transfer of uRBCs to explore basal RBC entry into the
BM parenchyma
Three uninfected UBC-GFP mice were bled by cardiac puncture, and
RBCs were isolated by centrifugation, after which 106 RBCs (expressing
GFP) were resuspended in 200 ml of PBS (per mouse) and injected by
tail vein injection. This was repeated in triplicate. Nomore than 2 hours
after UBC-GFP RBC injection, the recipient mice underwent surgery to
expose theBM to quantify the localization of the injectedRBCs from the
donor mice.
Gametocyte treatment with cytochalasin D
To investigate effects on the capacity of mature gametocytes to trans-
migrate across the endothelium, donor mice were treated with phenyl-
hydrazine by intraperitoneal injection as previously described and
infected 2 days later with 106 P. bergheimCherryHsp70FLucef1a parasites
to produce mixed infections. These donor mice were treated 3 days
after infection with sulfadiazine in drinking water (as previously de-
scribed). Two days later, gametocytes were isolated and further puri-
fied byNycodenz centrifugation (under the same conditions as described
for schizont cultures). Purified gametocytes were incubated in 200 nM
cytochalasin D (Sigma-Aldrich, catalog no. C8273) in complete RPMI
media at 37°C. Four to 6 hours after incubation, parasites were washed
3× in PBS, and 106 parasites were resuspended in 200 ml of PBS (per
mouse) and injected intravenously into each one of four recipient Flk1-
GFP mice. This experiment was repeated in triplicate. Following in-
jection into the recipient mice, parameters were quantified as follows:
(i) total gametocyte numbers (all mice) and (ii) distance from the vas-
culature within no more than 2 hours after infection (two mice per
replicate). Distancewasmeasured to determinewhether transmigration
still occurred andwhethermobility away fromthe vasculature (andwithin
theparenchyma)was still possible.Measurements of bothparameterswere
performed using either LivingImage 4.4 software for bioluminescence
or Fiji for fluorescence-based quantifications.
Mouse treatment with sildenafil citrate for investigating
gametocyte distribution
To investigate the effects of sildenafil citrate on gametocyte deform-
ability in vivo, Balb/c or C57BL/6 mice were pretreated with phenyl-
hydrazine as previously described and infected with 106 P. berghei
mCherryHsp70FLucef1a-synchronized schizonts. At day 3 after infection,
control mice were treated with sulfadiazine in drinking water, whereas
experimental mice were given, in addition to sulfadiazine, daily intra-De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018peritoneal injections of sildenafil citrate (European Pharmacopoeia
Reference Standard, code: Y0001578, ID: 00G592) for 3 days. Sildenafil
citrate (40 mg/kg) was given to various mouse groups, and biolumi-
nescence in the spleen and BMareas wasmeasured daily over the 3 days
following treatment using an IVIS-Spectrum (Caliper) system.
Preparation of mouse organs for
immunofluorescence assays
Following IVM, organs were collected for immunofluorescence assays.
All organs, including the brain, lungs, heart, adipose tissue, spleen, liver,
kidneys, gut, and BM, were poured into a 50-ml Falcon tube containing
1×PBS [137mMNaCl (Sigma-Aldrich, S9888, 1 kg), 2.7mMKCl (Fluka
Chemie AG P9541, 1 kg), 10 mM Na2HPO4 (Sigma-Aldrich, S5136,
500 g), 1.8 mMKH2PO4 (Sigma-Aldrich, P5655), pH 7.4], which was
placed on ice or 4°C during further preparations. Initially, each organ
was placed on a petri dish and cut into 2-mm slices. The slices of each
organ were fixed in 15-ml Falcon tubes containing 2% PFA in PBS, in
at least 20× the volume of the tissue (calculated by volume displacement).
The Falcon tubes were placed in a rocker for 4 hours. After 4 hours,
the PFA solution was removed and replaced with 1× PBS containing
sodium azide (NaN3) at 20× the tissue volume. Tubes were again placed
in a rocker for 30 min. After 30 min, slices were washed three times in
cold 1× PBS. After the third wash, 30% sucrose containing NaN3 was
added to all tissues, covering 20× the volume of the tissues, and organs
were then stored overnight at 4°C. The next day, a piece of Styrofoam
was placed in a shallowmetal container, and dry ice was placed inside
this container. 2-Methyl butanewas poured over the dry ice, creating a
layer of liquid at the bottom of the container, until the depth filled was
1 cm. Before freezing, the 30% sucrose solution was poured away, and
the tissue sectionswerewashed twicewith 1×PBS.Cryomolds (5× 3 cm)
were used. The cryomolds were then filled with OCT (optimal cutting
temperature compound) solution and either transferred immediately to
a −80°C freezer or poured into the 2-methyl butane for 5 min. Once
frozen, the OCT changes from transparent liquid to solid opaque, at
which point the frozen blocks of tissues were placed on foil and kept
at −80°C until use. Tissues were then processed for sectioning in 5- to
50-mm slices using a Cryotome cryostat, and slices were placed on
glass slides at the point of cutting. The slides were placed at −20°C until
use for immunofluorescence assay (IFA).
Immunofluorescence assays of mouse organs
For each cryostat section, tissues were fixed for 3min by applying 400 ml
of 4% PFA and/or 70% ethanol onto the section, thinly spreading the
solution within the entire area of the slide. Tissue sections were then
washed twice with 1× PBS at room temperature. Permeabilization so-
lution (200 ml; 1× PBS/0.2% Triton X-100) was spread over the tissue,
and slides were incubated in a humid chamber for 10 min. Slides were
then washed 3× for 5min each time, with 1× PBS at room temperature.
Slides were blocked using 200 ml of 10% goat serum and incubated in a
humid chamber for 1 hour, followed by three washes for 5 min each,
with 1× PBS. After blocking, slides were incubated with the diluted
primary antibodies overnight at 4°C in a humid chamber. For fluores-
cent labeling, slides were then incubated with secondary antibodies for
45 min in a humid chamber and then washed 3× with 1× PBS at room
temperature. After addition of the secondary antibodies, 200 ml of 4′,6-
diamidino-2-phenylindole stain (5 mg/ml) in 1× PBS (1:2000) was
poured over the slides and incubated for 2 to 3min in a humid chamber.
The slides were then washed for 5 min in 1× PBS. After allowing the
slides to dry slightly (without allowing the tissues to dry out completely),12 of 15
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 a small dropofVECTASHIELDmounting agentwas added, and a 1-mm
coverslip was overlayed and pressed gently, ensuring that air bubbles
were fully removed. The slides were then sealed with nail polish.
Theprimaryantibodiesusedwereratmonoclonalanti–ICAM-1(Abcam,
catalog no. ab119871) (used at a dilution of 1:100 in 10% goat serum/PBS),
rabbit polyclonal anti-CD31 (Abcam, catalog no. ab28364) (used at a
dilution of 1:20 in 10% goat serum/PBS), rabbit polyclonal anti-CD71
(used at a dilution of 1:200 in 10%goat serum/PBS), and rabbit polyclonal
anti-CD163 (Santa Cruz Biotechnology, catalog no. sc-33560) (used at a
dilution of 1:100 in 10% goat serum/PBS). Mouse/human anti-CD44
antibodies conjugated to A647 (BioLegend, catalog no. 103017) were
used at a dilution of 1:100 in 10% goat serum/PBS. As secondary anti-
bodies, species-specific Alexa Fluor Cy5 were used at a final concentra-
tion of 0.2 mg/ml. Anti-rabbit IgG-Cy5was used at a dilution of 1:250 and
anti-rat IgG-Cy5 was used at a dilution of 1:50 in 10% goat serum/PBS.
Live imaging of iRBCs in vitro
For determination of parameters for initial machine-learning train-
ing settings for staging parasites, time lapse imaging of synchronous
stages was performed, using a previously published method (40). In
summary, 2 to 5 ml of bloodwere obtained by tail vein puncture, from
UBC-GFP transgenic mice infected with synchronous rings, tropho-
zoites, schizonts, or gametocytes of different ages. These were resus-
pended in 200 ml of 1× PBS and washed by centrifugation at 450g for
45 s. The iRBCs were washed two further times and finally resuspended
in 500 ml of 1× PBS. Glass-bottom dishes (35 mm;MaTeck) were coated
with concanavalin A (0.5 mg/ml) (Sigma-Aldrich) dissolved in dH2O.
Concanavalin Awas added to the glass surface, and the dish was placed
in a 37°C incubator for 30min. After 30min, it was washed off using 1×
PBS, and 250 ml of resuspended iRBCs was overlayed over the glass sur-
face and allowed to settle for 30min at 37°C. Thereafter, nonbound cells
were washed off using PBS, and 2 ml of prewarmed, phenol red–free
culture medium was added to the dish. The cells were imaged within
a 37°C incubation chamber of an LSM5 confocal microscope (specifics
described above). A 63×/1.4 NA oil immersion objective was used, and
Zeiss Zen software was used for image acquisition. Cells were viewed
using 488-nm (GFP) or 559-nm (mCherry) laser lines simultaneously
to detect the RBCs of the UBC-GFP mice and P. berghei parasites, re-
spectively. In addition to fluorescence intensity and overall shape, nu-
clear staining was used to differentiate further the various stages. For
this case, Hoechst was used as a nuclear dye and imaged simultaneously
using an argon laser to detect the 405-nm wavelength.
Parasite substaging
For the staging of parasites, we used CellProfiler and CellProfiler Ana-
lyst. We partitioned the cells into a training set and a testing set. The
bright-field and dark-field features of the training set were used to train
the ensemble. Once the ensemble was trained, we evaluated its predic-
tive power on the testing set. To demonstrate the generalizability of
this approach and to obtain error bars for our results, the procedurewas
10-fold cross-validated. Toprevent overfitting the data, the stopping cri-
terion of the trainingwas determined via fivefold internal cross-validation.
In addition, we analyzed which features have the most significant con-
tributions for the prediction of parasite stages by “leave one out” cross-
validation. The most important features were fluorescence intensity,
area, shape, and nuclear staining of the parasites. For the final sub-
staging, manual classifications were always performed for every par-
asite counted and included in the analysis and cross-checked with
the results obtained from the automatic analysis.De Niz et al., Sci. Adv. 2018;4 : eaat3775 23 May 2018Manual tracking and data analysis
Track projections
Gametocyte tracks over time derived from intravital movies were
analyzed using the “Cell tracking” and “MTrackJ” ImageJ plugins and
ImarisTrack. A total of 500 different gametocytes were tracked for up
to 1 min or the duration of their presence in the field of recording.
Velocity
Speed of motion was calculated as the sum of distances between track
locations, measured using Volocity 6.3 software (PerkinElmer), and di-
vided by track duration. The presence of parasites per movie lasted for
varying amounts of time depending on the tissue and extravascular or
intravascular presence. For normalization purposes, all calculations
were based on 1 to 20 measurements acquired in 500-ms intervals.
Calculation of time spent in contact with vessels (lag time)
To calculate the lag time, or the time during which gametocytes made
contact with and arrested, videos acquired over a 5-min time lapse were
used. Lag time was identified from the calculation of average speed
through time (total arrest being equal to zero), as well as average game-
tocyte speed in relation to the speed of neighboring circulating RBCs or
parasites. Lag was considered a decrease in speed by 50% or more com-
pared to total cell and gametocyte speed.
Calculation of overall proximity to vessels
In Flk1-GFPmice, the vasculature is GFP-tagged. InUBC-GFPmice, the
vascular wall in various organs is visible because of the accumulation of
GFP. In addition, in C57BL/6 mice, the vasculature was labeled by injec-
tion of FITC-conjugated dextran. Proximity of gametocytes to the ves-
sel wall, as well as number of transmigrations, was calculated using the
Volocity 6.3 software (PerkinElmer) or Fiji.
Leakage quantification
The images obtained from intravital images ofmice injectedwith FITC-
labeled dextran were converted to a false-color scale (rainbow color)
based on dextran fluorescent intensity using ImageJ. Then, the blood
vessel area and interstitial space were manually circumscribed, and
the MFIs of each area were measured every 500 ms. For determination
of individual leakage caused by single parasites, a region of interest was
generated, and fluorescence changes (MFI) over a 5-min interval were
quantified.
Statistical analysis
Data were displayed in box plots or histograms generated using PRISM
6.0 software. Means, medians, interquartile ranges, and SDs were cal-
culated from three to five independent experiments performed in trip-
licate, using STATA 13.0 software. The P values were calculated using
Student’s t test or analysis of variance (ANOVA) in STATA 13.0. Sig-
nificance between samples is indicated with asterisks as follows: *P <
0.05; **P < 0.01; ***P < 0.001; n.s., not significant.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/5/eaat3775/DC1
fig. S1. Parasite localization in mixed stage infections and gametocyte sublocalization to BM
subcompartments.
fig. S2. Parasite clearance, homing, and vascular leakage in BM.
fig. S3. Dynamics of vascular leakage during infection.
fig. S4. Leakage induced by transmigration and sequestration.
fig. S5. Mature gametocyte distribution and mobility.
movie S1. Intravital imaging of BM in a Balb/c mouse infected with P. berghei ANKA mCherryHsp70
and intravenously injected with 70-kDa FITC-labeled dextran 24 hours after infection.
movie S2. Single P. berghei mCherry gametocyte moving against the blood flow in a C57BL/6
mouse intravenously injected with FITC-dextran (at 24 hours after infection).
movie S3. Compiled movie set of transmigrating gametocyte events.13 of 15
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Dmovie S4. Compiled movie sets of gametocyte mobility in UBC-GFP mice.
movie S5. Multiple circulating and static purified gametocytes in the sinusoids (S), parenchyma (P),
and vasculature (IV) of a UBC-GFP mouse.
movie S6. Fast circulation of mature gametocytes within the BM vasculature of a UBC-GFP
C57BL/6 mouse.
movie S7. Fast circulation of mature gametocytes within the spleen vasculature of a UBC-GFP
transgenic mouse.
movie S8. Multiple circulating and static purified gametocytes in the sinusoids (S), parenchyma
(P), and vasculature (IV) of a UBC-GFP mouse.
movie S9. Multiple circulating and static purified gametocytes in the sinusoids (S), parenchyma
(P), and vasculature (IV) of a UBC-GFP mouse.
movie S10. Multiple circulating and static purified gametocytes in the sinusoids (S), parenchyma
(P), and vasculature (IV) of a UBC-GFP mouse.
movie S11. Multiple circulating and static purified gametocytes in the sinusoids (S), parenchyma
(P), and vasculature (IV) of a UBC-GFP mouse.
movie S12. Multiple fast-circulating gametocytes in a vascular tree of the spleen of a UBC-GFP
mouse.
movie S13. Leukocyte motility, crawling adhesion, diapedesis (image center and top), and
accumulation at the vessel wall (image bottom) of a Lys-GFP control mouse.
table S1. This table contains the normalized expression values across all the 456 genes
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